Vitamin D and the RNA transcriptome: More than mRNA regulation

Frontiers in Physiology

Volumn 5 MAY, Issue , 2014, Pages

  Campbell, Moray J ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Epigenetic; Microarray; MicroRNA; Transcriptome; VDR

Indexed keywords

BETA CATENIN; COMPLEMENT FACTOR H; COP9 SIGNALOSOME SUBUNIT 2; CYCLIN D3; E1A ASSOCIATED P300 PROTEIN; HAIR GROWTH ASSOCIATED PROTEIN; MEMBRANE PROTEIN; NAKED CUTICLE HOMOLOG 2; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 3; NUCLEAR COREPRESSOR 1; NUCLEAR RECEPTOR COACTIVATOR 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING PROTEIN; PROLINE CARBOXYPEPTIDASE; PROTEIN P53; PROTEIN SNW1; PROTEIN SRPK1; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; SMAD3 PROTEIN; UNCLASSIFIED DRUG; UNTRANSLATED RNA; VITAMIN D RECEPTOR;

BINDING SITE; ENZYME ACTIVATION; ENZYME REGULATION; GENE CONTROL; GENETIC ASSOCIATION; GENETIC CODE; GENETIC VARIABILITY; HUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; RNA TRANSCRIPTION; TRANSCRIPTION REGULATION;

EID: 84904344387     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00181     Document Type: Review

References (167)

1. Akutsu, N., Lin, R., Bastien, Y., Bestawros, A., Enepekides, D. J., Black, M. J., et al. (2001). Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells. Mol. Endocrinol. 15, 1127-1139. doi: 10.1210/mend.15.7.0655.
2. Alvarez-Diaz, S., Valle, N., Ferrer-Mayorga, G., Lombardia, L., Herrera, M., Dominguez, O., et al. (2012). MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells. Hum. Mol. Genet. 21, 2157-2165. doi: 10.1093/hmg/dds031.
3. Amir, S., Ma, A. H., Shi, X. B., Xue, L., Kung, H. J., and Devere White, R. W. (2013). Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer. PLoS ONE 8:e61064. doi: 10.1371/journal.pone.0061064.
4. Anderson, P. H., O'Loughlin, P. D., May, B. K., and Morris, H. A. (2003). Quantification of mRNA for the vitamin D metabolizing enzymes CYP27B1 and CYP24 and vitamin D receptor in kidney using real-time reverse transcriptase-polymerase chain reaction. J. Mol. Endocrinol. 31, 123-132. doi: 10.1677/jme.0.0310123.
5. Aubol, B. E., Jamros, M. A., McGlone, M. L., and Adams, J. A. (2013). Splicing kinase SRPK1 conforms to the landscape of its SR protein substrate. Biochemistry 52, 7595-7605. doi: 10.1021/bi4010864.
6. Baeke, F., Korf, H., Overbergh, L., Verstuyf, A., Thorrez, L., Van Lommel, L., et al. (2011). The vitamin D analog, TX527, promotes a human CD4+CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation. J. Immunol. 186, 132-142. doi: 10.4049/jimmunol.1000695.
7. Baker, A. R., McDonnell, D. P., Hughes, M., Crisp, T. M., Mangelsdorf, D. J., Haussler, M. R., et al. (1988). Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. U.S.A. 85, 3294-3298. doi: 10.1073/pnas.85.10.3294.
8. Barrett, T., Suzek, T. O., Troup, D. B., Wilhite, S. E., Ngau, W. C., Ledoux, P., et al. (2005). NCBI GEO: mining millions of expression profiles-database and tools. Nucleic Acids Res. 33, D562-D566. doi: 10.1093/nar/gki022.
9. Barrett, T., Wilhite, S. E., Ledoux, P., Evangelista, C., Kim, I. F., Tomashevsky, M., et al. (2013). NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res. 41, D991-D995. doi: 10.1093/nar/gks1193.
10. Baudino, T. A., Kraichely, D. M., Jefcoat, S. C. Jr., Winchester, S. K., Partridge, N. C., and MacDonald, P. N. (1998). Isolation and characterization of a novel coactivator protein, NCoA-62, involved in vitamin D-mediated transcription. J. Biol. Chem. 273, 16434-16441. doi: 10.1074/jbc.273.26.16434.
11. Birney, E. (2012). The making of ENCODE: lessons for big-data projects. Nature 489, 49-51. doi: 10.1038/489049a.
12. Birney, E., Stamatoyannopoulos, J. A., Dutta, A., Guigo, R., Gingeras, T. R., Margulies, E. H., et al. (2007). Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799-816. doi: 10.1038/nature05874.
13. Bosse, Y., Maghni, K., and Hudson, T. J. (2007). 1alpha,25-dihydroxy-vitamin D3 stimulation of bronchial smooth muscle cells induces autocrine, contractility, and remodeling processes. Physiol. Genomics 29, 161-168. doi: 10.1152/physiolgenomics.00134.2006.
14. Boyle, A. P., Hong, E. L., Hariharan, M., Cheng, Y., Schaub, M. A., Kasowski, M., et al. (2012). Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 22, 1790-1797. doi: 10.1101/gr.137323.112.
15. Brader, L., Rejnmark, L., Carlberg, C., Schwab, U., Kolehmainen, M., Rosqvist, F., et al. (2014). Effects of a healthy Nordic diet on plasma 25-hydroxyvitamin D concentration in subjects with metabolic syndrome: a randomized, placebo-controlled trial (SYSDIET). Eur. J. Nutr. doi: 10.1007/s00394-014-0674-3. [Epub ahead of print].
16. Brazma, A., Hingamp, P., Quackenbush, J., Sherlock, G., Spellman, P., Stoeckert, C., et al. (2001). Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29, 365-371. doi: 10.1038/ng1201-365.
17. Campbell, M. J., Elstner, E., Holden, S., Uskokovic, M., and Koeffler, H. P. (1997). Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin. J. Mol. Endocrinol. 19, 15-27. doi: 10.1677/jme.0.0190015.
18. Carlberg, C., and Campbell, M. J. (2013). Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids 78, 127-136. doi: 10.1016/j.steroids.2012.10.019.
19. Carroll, J. S., Meyer, C. A., Song, J., Li, W., Geistlinger, T. R., Eeckhoute, J., et al. (2006). Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 38, 1289-1297. doi: 10.1038/ng1901.
20. Cenciarelli, C., De Santa, F., Puri, P. L., Mattei, E., Ricci, L., Bucci, F., et al. (1999). Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation. Mol. Cell. Biol. 19, 5203-5217.
21. Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., et al. (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997-1006. doi: 10.1038/cr.2008.282.
22. Colston, K., Colston, M. J., Fieldsteel, A. H., and Feldman, D. (1982). 1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines. Cancer Res. 42, 856-859.
23. Colston, K. W., Berger, U., and Coombes, R. C. (1989). Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1, 188-191.
24. Consortium, E. P., Birney, E., Stamatoyannopoulos, J. A., Dutta, A., Guigo, R., Gingeras, T. R., et al. (2007). Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799-816. doi: 10.1038/nature05874.
25. Consortium, G. T. (2013). The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580-585. doi: 10.1038/ng.2653.
26. Costa, J. L., Eijk, P. P., van de Wiel, M. A., ten Berge, D., Schmitt, F., Narvaez, C. J., et al. (2009). Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down. BMC Genomics 10:499. doi: 10.1186/1471-2164-10-499.
27. Cui, M., Klopot, A., Jiang, Y., and Fleet, J. C. (2009). The effect of differentiation on 1,25 dihydroxyvitamin D-mediated gene expression in the enterocyte-like cell line, Caco-2. J. Cell. Physiol. 218, 113-121. doi: 10.1002/jcp.21574.
28. Despouy, G., Bastie, J. N., Deshaies, S., Balitrand, N., Mazharian, A., Rochette-Egly, C., et al. (2003). Cyclin D3 is a cofactor of retinoic acid receptors, modulating their activity in the presence of cellular retinoic acid-binding protein II. J. Biol. Chem. 278, 6355-6362. doi: 10.1074/jbc.M210697200.
29. Ding, N., Yu, R. T., Subramaniam, N., Sherman, M. H., Wilson, C., Rao, R., et al. (2013). A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 153, 601-613. doi: 10.1016/j.cell.2013.03.028.
30. Do, J. H., and Choi, D. K. (2006). Normalization of microarray data: single-labeled and dual-labeled arrays. Mol. Cells 22, 254-261.
31. Dobrzynski, M., and Bruggeman, F. J. (2009). Elongation dynamics shape bursty transcription and translation. Proc. Natl. Acad. Sci. U.S.A. 106, 2583-2588. doi: 10.1073/pnas.0803507106.
32. Doig, C. L., Singh, P. K., Dhiman, V. K., Thorne, J. L., Battaglia, S., Sobolewski, M., et al. (2013). Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns. Carcinogenesis 34, 248-256. doi: 10.1093/carcin/bgs331.
33. Doolittle, W. F. (2013). Is junk DNA bunk? A critique of ENCODE. Proc. Natl. Acad. Sci. U.S.A. 110, 5294-5300. doi: 10.1073/pnas.1221376110.
34. Drake, M. T., Maurer, M. J., Link, B. K., Habermann, T. M., Ansell, S. M., Micallef, I. N., et al. (2010). Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J. Clin. Oncol. 28, 4191-4198. doi: 10.1200/JCO.2010.28.6674.
35. Dunlop, T. W., Vaisanen, S., Frank, C., and Carlberg, C. (2004). The genes of the coactivator TIF2 and the corepressor SMRT are primary 1alpha,25(OH)2D3 targets. J. Steroid Biochem. Mol. Biol. 89-90, 257-260. doi: 10.1016/j.jsbmb.2004.03.079.
36. Dwivedi, P. P., Omdahl, J. L., Kola, I., Hume, D. A., and May, B. K. (2000). Regulation of rat cytochrome P450C24 (CYP24) gene expression. Evidence for functional cooperation of Ras-activated Ets transcription factors with the vitamin D receptor in 1,25-dihydroxyvitamin D(3)-mediated induction. J. Biol. Chem. 275, 47-55. doi: 10.1074/jbc.275.1.47.
37. Eelen, G., Verlinden, L., Van Camp, M., Mathieu, C., Carmeliet, G., Bouillon, R., et al. (2004). Microarray analysis of 1alpha,25-dihydroxyvitamin D3-treated MC3T3-E1 cells. J. Steroid Biochem. Mol. Biol. 89-90, 405-407. doi: 10.1016/j.jsbmb.2004.03.008.
38. El-Hefnawy, T., Raja, S., Kelly, L., Bigbee, W. L., Kirkwood, J. M., Luketich, J. D., et al. (2004). Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics. Clin. Chem. 50, 564-573. doi: 10.1373/clinchem.2003.028506.
39. Ellison, T. I., Smith, M. K., Gilliam, A. C., and MacDonald, P. N. (2008). Inactivation of the vitamin D receptor enhances susceptibility of murine skin to UV-induced tumorigenesis. J. Invest. Dermatol. 128, 2508-2517. doi: 10.1038/jid.2008.131.
40. Elstner, E., Campbell, M. J., Munker, R., Shintaku, P., Binderup, L., Heber, D., et al. (1999). Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells. Prostate 40, 141-149. doi: 10.1002/(SICI)1097-0045(19990801)40:3%3C141::AID-PROS1%3E3.0.CO;2-C.
41. Engreitz, J. M., Chen, R., Morgan, A. A., Dudley, J. T., Mallelwar, R., and Butte, A. J. (2011). ProfileChaser: searching microarray repositories based on genome-wide patterns of differential expression. Bioinformatics 27, 3317-3318. doi: 10.1093/bioinformatics/btr548.
42. Gatfield, D., Le Martelot, G., Vejnar, C. E., Gerlach, D., Schaad, O., Fleury-Olela, F., et al. (2009). Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Dev. 23, 1313-1326. doi: 10.1101/gad.1781009.
43. 2+ channel transient receptor potential cation channel V5 (TRPV5). J. Biol. Chem. 279, 26351-26357. doi: 10.1074/jbc.M403801200.
44. Goldberg, A. D., Allis, C. D., and Bernstein, E. (2007). Epigenetics: a landscape takes shape. Cell 128, 635-638. doi: 10.1016/j.cell.2007.02.006.
45. Goyal, A., Delves, G. H., Chopra, M., Lwaleed, B. A., and Cooper, A. J. (2006). Prostate cells exposed to lycopene in vitro liberate lycopene-enriched exosomes. BJU Int. 98, 907-911. doi: 10.1111/j.1464-410X.2006.06434.x.
46. Guan, H., Liu, C., Chen, Z., Wang, L., Li, C., Zhao, J., et al. (2013). 1,25-Dihydroxyvitamin D3 up-regulates expression of hsa-let-7a-2 through the interaction of VDR/VDRE in human lung cancer A549 cells. Gene 522, 142-146. doi: 10.1016/j.gene.2013.03.065.
47. Gynther, P., Toropainen, S., Matilainen, J. M., Seuter, S., Carlberg, C., and Vaisanen, S. (2011). Mechanism of 1alpha,25-dihydroxyvitamin D(3)-dependent repression of interleukin-12B. Biochim. Biophys. Acta 1813, 810-818. doi: 10.1016/j.bbamcr.2011.01.037.
48. Hayes, G. M., Carrigan, P. E., Beck, A. M., and Miller, L. J. (2006). Targeting the RNA splicing machinery as a novel treatment strategy for pancreatic carcinoma. Cancer Res. 66, 3819-3827. doi: 10.1158/0008-5472.CAN-05-4065.
49. Heikkinen, S., Vaisanen, S., Pehkonen, P., Seuter, S., Benes, V., and Carlberg, C. (2011). Nuclear hormone 1alpha,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res. 39, 9181-9193. doi: 10.1093/nar/gkr654.
50. Hengst, L., and Reed, S. I. (1996). Translational control of p27Kip1 accumulation during the cell cycle. Science 271, 1861-1864. doi: 10.1126/science.271.5257.1861.
51. Hsieh, J. C., Sisk, J. M., Jurutka, P. W., Haussler, C. A., Slater, S. A., Haussler, M. R., et al. (2003). Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling. J. Biol. Chem. 278, 38665-38674. doi: 10.1074/jbc.M304886200.
52. Huang, Y. C., Chen, J. Y., and Hung, W. C. (2004). Vitamin D(3) receptor/Sp1 complex is required for the induction of p27(Kip1) expression by vitamin D(3). Oncogene. doi: 10.1038/sj.onc.1207621.
53. Iosue, I., Quaranta, R., Masciarelli, S., Fontemaggi, G., Batassa, E. M., Bertolami, C., et al. (2013). Argonaute 2 sustains the gene expression program driving human monocytic differentiation of acute myeloid leukemia cells. Cell Death Dis. 4, e926. doi: 10.1038/cddis.2013.452.
54. Ito, I., Waku, T., Aoki, M., Abe, R., Nagai, Y., Watanabe, T., et al. (2013). A nonclassical vitamin D receptor pathway suppresses renal fibrosis. J. Clin. Invest. 123, 4579-4594. doi: 10.1172/JCI67804.
55. Ivanovska, I., Ball, A. S., Diaz, R. L., Magnus, J. F., Kibukawa, M., Schelter, J. M., et al. (2008). MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol. Cell. Biol. 28, 2167-2174. doi: 10.1128/MCB.01977-07.
56. Jenuwein, T., and Allis, C. D. (2001). Translating the histone code. Science 293, 1074-1080. doi: 10.1126/science.1063127.
57. Jiang, F., Li, P., Fornace, A. J. Jr., Nicosia, S. V., and Bai, W. (2003). G2/M arrest by 1,25-dihydroxyvitamin D3 in ovarian cancer cells mediated through the induction of GADD45 via an exonic enhancer. J. Biol. Chem. 278, 48030-48040. doi: 10.1074/jbc.M308430200.
58. Jiang, Y. J., and Bikle, D. D. (2014). LncRNA: a new player in 1alpha, 25(OH)2 vitamin D3/VDR protection against skin cancer formation. Exp. Dermatol. 23, 147-150. doi: 10.1111/exd.12341.
59. Kangaspeska, S., Stride, B., Metivier, R., Polycarpou-Schwarz, M., Ibberson, D., Carmouche, R. P., et al. (2008). Transient cyclical methylation of promoter DNA. Nature 452, 112-115. doi: 10.1038/nature06640.
60. Kapranov, P., and St Laurent, G. (2012). Dark matter RNA: existence, function, and controversy. Front. Genet. 3:60. doi: 10.3389/fgene.2012.00060.
61. Katoh, M., and Katoh, M. (2007). WNT signaling pathway and stem cell signaling network. Clin. Cancer Res. 13, 4042-4045. doi: 10.1158/1078-0432.CCR-06-2316.
62. Khanim, F. L., Gommersall, L. M., Wood, V. H., Smith, K. L., Montalvo, L., O'Neill, L. P., et al. (2004). Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells. Oncogene 23, 6712-6725. doi: 10.1038/sj.onc.1207772.
63. Kim, J. Y., Son, Y. L., and Lee, Y. C. (2009). Involvement of SMRT Corepressor in Transcriptional Repression by the Vitamin D Receptor. Mol. Endocrinol. 23, 251-264. doi: 10.1210/me.2008-0426.
64. Kim, S., Shevde, N. K., and Pike, J. W. (2005). 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts. J. Bone Miner. Res. 20, 305-317. doi: 10.1359/JBMR.041112.
65. Koike, M., Elstner, E., Campbell, M. J., Asou, H., Uskokovic, M., Tsuruoka, N., et al. (1997). 19-nor-hexafluoride analogue of vitamin D3: a novel class of potent inhibitors of proliferation of human breast cell lines. Cancer Res. 57, 4545-4550.
66. Kommagani, R., Caserta, T. M., and Kadakia, M. P. (2006). Identification of vitamin D receptor as a target of p63. Oncogene 25, 3745-3751. doi: 10.1038/sj.onc.1209412.
67. Kovalenko, P. L., Zhang, Z., Yu, J. G., Li, Y., Clinton, S. K., and Fleet, J. C. (2011). Dietary vitamin D and vitamin D receptor level modulate epithelial cell proliferation and apoptosis in the prostate. Cancer Prev. Res. (Phila.) 4, 1617-1625. doi: 10.1158/1940-6207.CAPR-11-0035.
68. Lai, Y., Zhang, F., Nayak, T. K., Modarres, R., Lee, N. H., and McCaffrey, T. A. (2014). Concordant integrative gene set enrichment analysis of multiple large-scale two-sample expression data sets. BMC Genomics 15(Suppl. 1), S6. doi: 10.1186/1471-2164-15-S1-S6.
69. Lambert, J. R., Kelly, J. A., Shim, M., Huffer, W. E., Nordeen, S. K., Baek, S. J., et al. (2006). Prostate derived factor in human prostate cancer cells: gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth. J. Cell. Physiol. 208, 566-574. doi: 10.1002/jcp.20692.
70. Lazaro, J. B., Bailey, P. J., and Lassar, A. B. (2002). Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation. Genes Dev. 16, 1792-1805. doi: 10.1101/gad.U-9988R.
71. Le May, N., Mota-Fernandes, D., Velez-Cruz, R., Iltis, I., Biard, D., and Egly, J. M. (2010). NER factors are recruited to active promoters and facilitate chromatin modification for transcription in the absence of exogenous genotoxic attack. Mol. Cell 38, 54-66. doi: 10.1016/j.molcel.2010.03.004.
72. Leong, G. M., Subramaniam, N., Figueroa, J., Flanagan, J. L., Hayman, M. J., Eisman, J. A., et al. (2001). Ski-interacting protein interacts with Smad proteins to augment transforming growth factor-beta-dependent transcription. J. Biol. Chem. 276, 18243-18248. doi: 10.1074/jbc.M010815200.
73. Li, P., Li, C., Zhao, X., Zhang, X., Nicosia, S. V., and Bai, W. (2004). p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase. J. Biol. Chem. 279, 25260-25267. doi: 10.1074/jbc.M311052200.
74. Lin, R., Nagai, Y., Sladek, R., Bastien, Y., Ho, J., Petrecca, K., et al. (2002). Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Mol. Endocrinol. 16, 1243-1256. doi: 10.1210/mend.16.6.0874.
75. Ling, H., Fabbri, M., and Calin, G. A. (2013). MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat. Rev. Drug Discov. 12, 847-865. doi: 10.1038/nrd4140.
76. Lisse, T. S., Liu, T., Irmler, M., Beckers, J., Chen, H., Adams, J. S., et al. (2011). Gene targeting by the vitamin D response element binding protein reveals a role for vitamin D in osteoblast mTOR signaling. FASEB J. 25, 937-947. doi: 10.1096/fj.10-172577.
77. Liu, C. G., Calin, G. A., Volinia, S., and Croce, C. M. (2008). MicroRNA expression profiling using microarrays. Nat. Protoc. 3, 563-578. doi: 10.1038/nprot.2008.14.
78. Liu, M., Lee, M. H., Cohen, M., Bommakanti, M., and Freedman, L. P. (1996). Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10, 142-153. doi: 10.1101/gad.10.2.142.
79. Lupien, M., Eeckhoute, J., Meyer, C. A., Wang, Q., Zhang, Y., Li, W., et al. (2008). FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132, 958-970. doi: 10.1016/j.cell.2008.01.018.
80. Lussier, Y. A., Stadler, W. M., and Chen, J. L. (2012). Advantages of genomic complexity: bioinformatics opportunities in microRNA cancer signatures. J. Am. Med. Inform. Assoc. 19, 156-160. doi: 10.1136/amiajnl-2011-000419.
81. Mahajan, M. A., and Samuels, H. H. (2000). A new family of nuclear receptor coregulators that integrate nuclear receptor signaling through CREB-binding protein. Mol. Cell. Biol. 20, 5048-5063. doi: 10.1128/MCB.20.14.5048-5063.2000.
82. Maher, B. (2012). ENCODE: The human encyclopaedia. Nature 489, 46-48. doi: 10.1038/489046a.
83. Malinen, M., Saramaki, A., Ropponen, A., Degenhardt, T., Vaisanen, S., and Carlberg, C. (2008). Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and 1alpha,25-dihydroxyvitamin D3. Nucleic Acids Res. 36, 121-132. doi: 10.1093/nar/gkm913.
84. Mangan, S., and Alon, U. (2003). Structure and function of the feed-forward loop network motif. Proc. Natl. Acad. Sci. U.S.A. 100, 11980-11985. doi: 10.1073/pnas.2133841100.
85. Mangan, S., Itzkovitz, S., Zaslaver, A., and Alon, U. (2006). The incoherent feed-forward loop accelerates the response-time of the gal system of Escherichia coli. J. Mol. Biol. 356, 1073-1081. doi: 10.1016/j.jmb.2005.12.003.
86. Marinelli, R. J., Montgomery, K., Liu, C. L., Shah, N. H., Prapong, W., Nitzberg, M., et al. (2008). The stanford tissue microarray database. Nucleic Acids Res. 36, D871-D877. doi: 10.1093/nar/gkm861.
87. Martinez-Climent, J. A., Fontan, L., Fresquet, V., Robles, E., Ortiz, M., and Rubio, A. (2010). Integrative oncogenomic analysis of microarray data in hematologic malignancies. Methods Mol. Biol. 576, 231-277. doi: 10.1007/978-1-59745-545-9_13.
88. Maruyama, R., Aoki, F., Toyota, M., Sasaki, Y., Akashi, H., Mita, H., et al. (2006). Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation. Cancer Res. 66, 4574-4583. doi: 10.1158/0008-5472.CAN-05-2562.
89. Metivier, R., Gallais, R., Tiffoche, C., Le Peron, C., Jurkowska, R. Z., Carmouche, R. P., et al. (2008). Cyclical DNA methylation of a transcriptionally active promoter. Nature 452, 45-50. doi: 10.1038/nature06544.
90. Metivier, R., Penot, G., Hubner, M. R., Reid, G., Brand, H., Kos, M., et al. (2003). Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115, 751-763. doi: 10.1016/S0092-8674(03)00934-6.
91. Meyer, M. B., Goetsch, P. D., and Pike, J. W. (2012). VDR/RXR and TCF4/beta-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression. Mol. Endocrinol. 26, 37-51. doi: 10.1210/me.2011-1109.
92. Meyer, M. B., Watanuki, M., Kim, S., Shevde, N. K., and Pike, J. W. (2006). The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. Mol. Endocrinol. 20, 1447-1461. doi: 10.1210/me.2006-0031.
93. Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A. 105, 10513-10518. doi: 10.1073/pnas.0804549105.
94. Mohn, F., and Schubeler, D. (2009). Genetics and epigenetics: stability and plasticity during cellular differentiation. Trends Genet. 25, 129-136. doi: 10.1016/j.tig.2008.12.005.
95. Mohri, T., Nakajima, M., Takagi, S., Komagata, S., and Yokoi, T. (2009). MicroRNA regulates human vitamin D receptor. Int. J. Cancer 125, 1328-1333. doi: 10.1002/ijc.24459.
96. Novershtern, N., Subramanian, A., Lawton, L. N., Mak, R. H., Haining, W. N., McConkey, M. E., et al. (2011). Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 144, 296-309. doi: 10.1016/j.cell.2011.01.004.
97. Orlov, I., Rochel, N., Moras, D., and Klaholz, B. P. (2012). Structure of the full human RXR/VDR nuclear receptor heterodimer complex with its DR3 target DNA. EMBO J. 31, 291-300. doi: 10.1038/emboj.2011.445.
98. Osoegawa, K., Tateno, M., Woon, P. Y., Frengen, E., Mammoser, A. G., Catanese, J. J., et al. (2000). Bacterial artificial chromosome libraries for mouse sequencing and functional analysis. Genome Res. 10, 116-128.
99. Padi, S. K., Zhang, Q., Rustum, Y. M., Morrison, C., and Guo, B. (2013). MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice. Gastroenterology 145, 437-446. doi: 10.1053/j.gastro.2013.04.012.
100. Pálmer, H. G., González-Sancho, J. M., Espada, J., Berciano, M. T., Puig, I., Baulida, J., et al. (2001). Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J. Cell. Biol. 154, 369-387. doi: 10.1083/jcb.200102028.
101. Pálmer, H. G., Sánchez-Carbayo, M., Ordóñez-Morán, P., Larriba, M. J., Cordón-Cardó, C, and Muñoz, A. (2003). Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res. 63, 7799-7806.
102. Parkinson, H., Kapushesky, M., Shojatalab, M., Abeygunawardena, N., Coulson, R., Farne, A., et al. (2007). ArrayExpress-a public database of microarray experiments and gene expression profiles. Nucleic Acids Res. 35, D747-D750. doi: 10.1093/nar/gkl995.
103. Peehl, D. M., Skowronski, R. J., Leung, G. K., Wong, S. T., Stamey, T. A., and Feldman, D. (1994). Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res. 54, 805-810.
104. Peleg, S., and Nguyen, C. V. (2010). The importance of nuclear import in protection of the vitamin D receptor from polyubiquitination and proteasome-mediated degradation. J. Cell. Biochem. 110, 926-934. doi: 10.1002/jcb.22606.
105. Pereira, F., Barbachano, A., Silva, J., Bonilla, F., Campbell, M. J., Munoz, A., et al. (2011). KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. Hum. Mol. Genet. 20, 4655-4665. doi: 10.1093/hmg/ddr399.
106. Pihlajamaa, P., Sahu, B., Lyly, L., Aittomaki, V., Hautaniemi, S., and Janne, O. A. (2014). Tissue-specific pioneer factors associate with androgen receptor cistromes and transcription programs. EMBO J. 33, 312-326. doi: 10.1002/embj.201385895.
107. Pike, J. W., Gooze, L. L., and Haussler, M. R. (1980). Biochemical evidence for 1,25-dihydroxyvitamin D receptor macromolecules in parathyroid, pancreatic, pituitary, and placental tissues. Life Sci. 26, 407-414. doi: 10.1016/0024-3205(80)90158-7.
108. Polly, P., Herdick, M., Moehren, U., Baniahmad, A., Heinzel, T., and Carlberg, C. (2000). VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor partnership. FASEB J. 14, 1455-1463. doi: 10.1096/fj.14.10.1455.
109. Quack, M., and Carlberg, C. (2000). The impact of functional vitamin D(3) receptor conformations on DNA-dependent vitamin D(3) signaling. Mol. Pharmacol. 57, 375-384.
110. Rabinowits, G., Gercel-Taylor, C., Day, J. M., Taylor, D. D., and Kloecker, G. H. (2009). Exosomal microRNA: a diagnostic marker for lung cancer. Clin. Lung Cancer. 10, 42-46. doi: 10.3816/CLC.2009.n.006.
111. Ramagopalan, S. V., Heger, A., Berlanga, A. J., Maugeri, N. J., Lincoln, M. R., Burrell, A., et al. (2010). A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 20, 1352-1360. doi: 10.1101/gr.107920.110.
112. Rantala, J. K., Edgren, H., Lehtinen, L., Wolf, M., Kleivi, K., Vollan, H. K., et al. (2010). Integrative functional genomics analysis of sustained polyploidy phenotypes in breast cancer cells identifies an oncogenic profile for GINS2. Neoplasia 12, 877-888.
113. Rashid, S. F., Moore, J. S., Walker, E., Driver, P. M., Engel, J., Edwards, C. E., et al. (2001). Synergistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafluoride analogs in combination with either sodium butyrate or trichostatin A. Oncogene 20, 1860-1872. doi: 10.1038/sj.onc.1204269.
114. Reid, G., Hubner, M. R., Metivier, R., Brand, H., Denger, S., Manu, D., et al. (2003). Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11, 695-707. doi: 10.1016/S1097-2765(03)00090-X.
115. Ribas, J., Ni, X., Haffner, M., Wentzel, E. A., Salmasi, A. H., Chowdhury, W. H., et al. (2009). miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res. 69, 7165-7169. doi: 10.1158/0008-5472.CAN-09-1448.
116. Rid, R., Wagner, M., Maier, C. J., Hundsberger, H., Hintner, H., Bauer, J. W., et al. (2013). Deciphering the calcitriol-induced transcriptomic response in keratinocytes: presentation of novel target genes. J. Mol. Endocrinol. 50, 131-149. doi: 10.1530/JME-11-0191.
117. Rosenbloom, K. R., Sloan, C. A., Malladi, V. S., Dreszer, T. R., Learned, K., Kirkup, V. M., et al. (2013). ENCODE data in the UCSC genome browser: year 5 update. Nucleic Acids Res. 41, D56-D63. doi: 10.1093/nar/gks1172.
118. Sahu, B., Laakso, M., Pihlajamaa, P., Ovaska, K., Sinielnikov, I., Hautaniemi, S., et al. (2013). FoxA1 specifies unique androgen and glucocorticoid receptor binding events in prostate cancer cells. Cancer Res. 73, 1570-1580. doi: 10.1158/0008-5472.CAN-12-2350.
119. Saramaki, A., Banwell, C. M., Campbell, M. J., and Carlberg, C. (2006). Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res. 34, 543-554. doi: 10.1093/nar/gkj460.
120. Saramaki, A., Diermeier, S., Kellner, R., Laitinen, H., Vaisanen, S., and Carlberg, C. (2009). Cyclical chromatin looping and transcription factor association on the regulatory regions of the p21 (CDKN1A) gene in response to 1alpha,25-dihydroxyvitamin D3. J. Biol. Chem. 284, 8073-8082. doi: 10.1074/jbc.M808090200.
121. Sarruf, D. A., Iankova, I., Abella, A., Assou, S., Miard, S., and Fajas, L. (2005). Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor gamma. Mol. Cell Biol. 25, 9985-9995. doi: 10.1128/MCB.25.22.9985-9995.2005.
122. Savli, H., Aalto, Y., Nagy, B., Knuutila, S., and Pakkala, S. (2002). Gene expression analysis of 1,25(OH)2D3-dependent differentiation of HL-60 cells: a cDNA array study. Br. J. Haematol. 118, 1065-1070. doi: 10.1046/j.1365-2141.2002.03734.x.
123. Schwaller, J., Koeffler, H. P., Niklaus, G., Loetscher, P., Nagel, S., Fey, M. F., et al. (1995). Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells. J. Clin. Invest. 95, 973-979. doi: 10.1172/JCI117806.
124. Scsucova, S., Palacios, D., Savignac, M., Mellstrom, B., Naranjo, J. R., and Aranda, A. (2005). The repressor DREAM acts as a transcriptional activator on Vitamin D and retinoic acid response elements. Nucleic Acids Res. 33, 2269-2279. doi: 10.1093/nar/gki503.
125. Seo, Y. K., Chung, Y. T., Kim, S., Echchgadda, I., Song, C. S., and Chatterjee, B. (2007). Xenobiotic-and vitamin D-responsive induction of the steroid/bile acid-sulfotransferase Sult2A1 in young and old mice: the role of a gene enhancer in the liver chromatin. Gene 386, 218-223. doi: 10.1016/j.gene.2006.10.006.
126. Serandour, A. A., Avner, S., Percevault, F., Demay, F., Bizot, M., Lucchetti-Miganeh, C., et al. (2011). Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. Genome Res. 21, 555-565. doi: 10.1101/gr.111534.110.
127. Shah, N. H., Jonquet, C., Chiang, A. P., Butte, A. J., Chen, R., and Musen, M. A. (2009). Ontology-driven indexing of public datasets for translational bioinformatics. BMC Bioinform. 10 (Suppl. 2), S1. doi: 10.1186/1471-2105-10-S2-S1.
128. Shanafelt, T. D., Drake, M. T., Maurer, M. J., Allmer, C., Rabe, K. G., and Slager, S. L., et al. (2011). Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 117, 1492-1498. doi: 10.1182/blood-2010-07-295683.
129. Shi, X. B., Xue, L., Ma, A. H., Tepper, C. G., Kung, H. J., and White, R. W. (2011). miR-125b promotes growth of prostate cancer xenograft tumor through targeting pro-apoptotic genes. Prostate 71, 538-549. doi: 10.1002/pros.21270.
130. Singh, P. K., Preus, L., Hu, Q., Yan, L., Long, M. D., Morrison, C. D., et al. (2014). Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients. Oncotarget 5, 824-840.
131. Song, G., and Wang, L. (2008). Transcriptional mechanism for the paired miR-433 and miR-127 genes by nuclear receptors SHP and ERRgamma. Nucleic Acids Res. 36, 5727-5735. doi: 10.1093/nar/gkn567.
132. Stamatoyannopoulos, J. A. (2012). What does our genome encode? Genome Res. 22, 1602-1611. doi: 10.1101/gr.146506.112.
133. Stambolsky, P., Tabach, Y., Fontemaggi, G., Weisz, L., Maor-Aloni, R., Siegfried, Z., et al. (2010). Modulation of the vitamin D3 response by cancer-associated mutant p53. Cancer Cell 17, 273-285. doi: 10.1016/j.ccr.2009.11.025.
134. Strausberg, R. L., Buetow, K. H., Greenhut, S. F., Grouse, L. H., and Schaefer, C. F. (2002). The cancer genome anatomy project: online resources to reveal the molecular signatures of cancer. Cancer Invest. 20, 1038-1050. doi: 10.1081/CNV-120005922.
135. Sun, T., Wang, Q., Balk, S., Brown, M., Lee, G. S., and Kantoff, P. (2009). The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines. Cancer Res. 69, 3356-3363. doi: 10.1158/0008-5472.CAN-08-4112.
136. Szeles, L., Poliska, S., Nagy, G., Szatmari, I., Szanto, A., Pap, A., et al. (2010). Research resource: transcriptome profiling of genes regulated by RXR and its permissive and nonpermissive partners in differentiating monocyte-derived dendritic cells. Mol. Endocrinol. 24, 2218-2231. doi: 10.1210/me.2010-0215.
137. Tagami, T., Lutz, W. H., Kumar, R., and Jameson, J. L. (1998). The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. Biochem. Biophys. Res. Commun. 253, 358-363. doi: 10.1006/bbrc.1998.9799.
138. Tagliafico, E., Tenedini, E., Manfredini, R., Grande, A., Ferrari, F., Roncaglia, E., et al. (2006). Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia. Leukemia 20, 1751-1758. doi: 10.1038/sj.leu.2404358.
139. Taylor, D. D., and Gercel-Taylor, C. (2008). MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol. 110, 13-21. doi: 10.1016/j.ygyno.2008.04.033.
140. Thorne, J. L., Maguire, O., Doig, C. L., Battaglia, S., Fehr, L., Sucheston, L. E., et al. (2011). Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells. Nucleic Acids Res. 39, 2045-2056. doi: 10.1093/nar/gkq875.
141. Ting, H. J., Messing, J., Yasmin-Karim, S., and Lee, Y. F. (2013). Identification of microRNA-98 as a therapeutic target inhibiting prostate cancer growth and a biomarker induced by vitamin D. J. Biol. Chem. 288, 1-9. doi: 10.1074/jbc.M112.395947.
142. Towsend, K., Trevino, V., Falciani, F., Stewart, P. M., Hewison, M., and Campbell, M. J. (2006). Identification of VDR-responsive gene signatures in breast cancer cells. Oncology 71, 111-123. doi: 10.1159/000100989.
143. Tress, M. L., Martelli, P. L., Frankish, A., Reeves, G. A., Wesselink, J. J., Yeats, C., et al. (2007). The implications of alternative splicing in the ENCODE protein complement. Proc. Natl. Acad. Sci. U.S.A. 104, 5495-5500. doi: 10.1073/pnas.0700800104.
144. Turner, B. M. (1993). Decoding the nucleosome. Cell 75, 5-8. doi: 10.1016/0092-8674(93)90673-E.
145. Turner, B. M. (1998). Histone acetylation as an epigenetic determinant of long-term transcriptional competence. Cell Mol. Life Sci. 54, 21-31. doi: 10.1007/s000180050122.
146. Turner, B. M. (2002). Cellular memory and the histone code. Cell 111, 285-291. doi: 10.1016/S0092-8674(02)01080-2.
147. Vaisanen, S., Dunlop, T. W., Sinkkonen, L., Frank, C., and Carlberg, C. (2005). Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3. J. Mol. Biol. 350, 65-77. doi: 10.1016/j.jmb.2005.04.057.
148. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J. J., and Lotvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659. doi: 10.1038/ncb1596.
149. Varjosalo, M., Keskitalo, S., Van Drogen, A., Nurkkala, H., Vichalkovski, A., Aebersold, R., et al. (2013). The protein interaction landscape of the human CMGC kinase group. Cell Rep. 3, 1306-1320. doi: 10.1016/j.celrep.2013.03.027.
150. Wang, F., Marshall, C. B., and Ikura, M. (2013a). Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition. Cell. Mol. Life Sci. 70, 3989-4008. doi: 10.1007/s00018-012-1254-4.
151. Wang, J., Huo, K., Ma, L., Tang, L., Li, D., Huang, X., et al. (2011a). Toward an understanding of the protein interaction network of the human liver. Mol. Syst. Biol. 7, 536. doi: 10.1038/msb.2011.67.
152. Wang, Q. M., Jones, J. B., and Studzinski, G. P. (1996). Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res. 56, 264-267.
153. Wang, T. T., Tavera-Mendoza, L. E., Laperriere, D., Libby, E., MacLeod, N. B., Nagai, Y., et al. (2005). Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol. Endocrinol. 19, 2685-2695. doi: 10.1210/me.2005-0106.
154. Wang, W. L., Chatterjee, N., Chittur, S. V., Welsh, J., and Tenniswood, M. P. (2011b). Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol. Cancer 10:58. doi: 10.1186/1476-4598-10-58.
155. Wang, W. L., Welsh, J., and Tenniswood, M. (2013b). 1,25-Dihydroxyvitamin D3 modulates lipid metabolism in prostate cancer cells through miRNA mediated regulation of PPARA. J. Steroid Biochem. Mol. Biol. 136, 247-251. doi: 10.1016/j.jsbmb.2012.09.033.
156. Wang, X., Gocek, E., Liu, C. G., and Studzinski, G. P. (2009). MicroRNAs181 regulate the expression of p27(Kip1) in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D(3). Cell Cycle 8, 736-741. doi: 10.4161/cc.8.5.7870.
157. Welsh, J., Wietzke, J. A., Zinser, G. M., Smyczek, S., Romu, S., Tribble, E., et al. (2002). Impact of the Vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer. J. Steroid Biochem. Mol. Biol. 83, 85-92. doi: 10.1016/S0960-0760(02)00277-7.
158. Yang, X., Bemis, L., Su, L. J., Gao, D., and Flaig, T. W. (2012). miR-125b Regulation of Androgen receptor signaling via modulation of the receptor complex co-repressor NCOR2. Biores. Open Access, 1, 55-62. doi: 10.1089/biores.2012.9903.
159. Yang, X., Downes, M., Yu, R. T., Bookout, A. L., He, W., Straume, M., et al. (2006). Nuclear receptor expression links the circadian clock to metabolism. Cell 126, 801-810. doi: 10.1016/j.cell.2006.06.050.
160. Yuan, C. X., Ito, M., Fondell, J. D., Fu, Z. Y., and Roeder, R. G. (1998). The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc. Natl. Acad. Sci. U.S.A. 95, 7939-7944. doi: 10.1073/pnas.95.14.7939.
161. Zella, L. A., Kim, S., Shevde, N. K., and Pike, J. W. (2006). Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Mol. Endocrinol. 20, 1231-1247. doi: 10.1210/me.2006-0015.
162. Zerr, P., Vollath, S., Palumbo-Zerr, K., Tomcik, M., Huang, J., Distler, A., et al. (2014). Vitamin D receptor regulates TGF-β signalling in systemic sclerosis. Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2013-204378. [Epub ahead of print].
163. Zhang, C., Dowd, D. R., Staal, A., Gu, C., Lian, J. B., van Wijnen, A. J., et al. (2003). Nuclear coactivator-62 kDa/Ski-interacting protein is a nuclear matrix-associated coactivator that may couple vitamin D receptor-mediated transcription and RNA splicing. J. Biol. Chem. 278, 35325-35336. doi: 10.1074/jbc.M305191200.
164. Zhang, L., Stokes, N., Polak, L., and Fuchs, E. (2011). Specific microRNAs are preferentially expressed by skin stem cells to balance self-renewal and early lineage commitment. Cell Stem Cell 8, 294-308. doi: 10.1016/j.stem.2011.01.014.
165. Zhang, Y., Szustakowski, J., and Schinke, M. (2009). Bioinformatics analysis of microarray data. Methods Mol. Biol. 573, 259-284. doi: 10.1007/978-1-60761-247-6_15.
166. Zhi, H. Y., Hou, S. W., Li, R. S., Basir, Z., Xiang, Q., Szabo, A., et al. (2011). PTPH1 cooperates with vitamin D receptor to stimulate breast cancer growth through their mutual stabilization. Oncogene 30, 1706-1715. doi: 10.1038/onc.2010.543.
167. Zhou, Y., Gong, W., Xiao, J., Wu, J., Pan, L., Li, X., et al. (2014). Transcriptomic analysis reveals key regulators of mammogenesis and the pregnancy-lactation cycle. Sci. China Life Sci. 57, 340-355. doi: 10.1007/s11427-013-4579-9.